These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29259266)

  • 1. Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population.
    Zhang Z; Chen Q; Zhang J; Wang Y; Hu X; Yin S; He M; Guan S; Qin W; Xiao Q; Zhao H; Yao W; Wu H; Wei M
    Sci Rep; 2017 Dec; 7(1):17844. PubMed ID: 29259266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
    Li X; Zhang R; Liu Z; Li S; Xu H
    Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population.
    Chen J; Shao P; Cao Q; Li P; Li J; Cai H; Zhu J; Wang M; Zhang Z; Qin C; Yin C
    PLoS One; 2012; 7(7):e40817. PubMed ID: 22815832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional variant in the MTOR promoter modulates its expression and is associated with renal cell cancer risk.
    Cao Q; Ju X; Li P; Meng X; Shao P; Cai H; Wang M; Zhang Z; Qin C; Yin C
    PLoS One; 2012; 7(11):e50302. PubMed ID: 23209702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the effect of rs2295080 and rs2536 polymorphisms within the mTOR gene on cancer risk.
    Qi GH; Wang CH; Zhang HG; Yu JG; Ding F; Song ZC; Xia QH
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32597485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of mTOR and cancer risk: a systematic review and updated meta-analysis.
    Zining J; Lu X; Caiyun H; Yuan Y
    Oncotarget; 2016 Aug; 7(35):57464-57480. PubMed ID: 27462867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The associations of hub gene polymorphisms in PI3K/AKT/mTOR pathway and Schistosomiasis Japonica infection and hepatic fibrosis.
    Xiao Q; Yu H; Zhu X
    Infect Genet Evol; 2020 Nov; 85():104423. PubMed ID: 32554084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer.
    Li Q; Yang J; Yu Q; Wu H; Liu B; Xiong H; Hu G; Zhao J; Yuan X; Liao Z
    Clin Cancer Res; 2013 Nov; 19(22):6252-60. PubMed ID: 24077347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of genetic variants in the PI3K/PTEN pathways in susceptibility to colorectal carcinoma and clinical outcomes treated with FOLFOX regimen.
    Lin L; Zhang Z; Zhang W; Wang L; Wang J
    Int J Clin Exp Pathol; 2015; 8(10):13314-22. PubMed ID: 26722535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
    Slattery ML; Herrick JS; Lundgreen A; Fitzpatrick FA; Curtin K; Wolff RK
    Carcinogenesis; 2010 Sep; 31(9):1604-11. PubMed ID: 20622004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.
    Xu JL; Wang ZW; Hu LM; Yin ZQ; Huang MD; Hu ZB; Shen HB; Shu YQ
    Asian Pac J Cancer Prev; 2012; 13(5):2157-62. PubMed ID: 22901187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of mTOR polymorphisms with cancer risk and clinical outcomes: a meta-analysis.
    Shao J; Li Y; Zhao P; Yue X; Jiang J; Liang X; He X
    PLoS One; 2014; 9(5):e97085. PubMed ID: 24816861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
    Hildebrandt MA; Yang H; Hung MC; Izzo JG; Huang M; Lin J; Ajani JA; Wu X
    J Clin Oncol; 2009 Feb; 27(6):857-71. PubMed ID: 19164214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Kang BW; Moon JH; Lee SJ; Jeon SW; Park JS; Park JY; Choi GS
    Oncology; 2010; 79(3-4):278-82. PubMed ID: 21412012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.
    Wang LE; Ma H; Hale KS; Yin M; Meyer LA; Liu H; Li J; Lu KH; Hennessy BT; Li X; Spitz MR; Wei Q; Mills GB
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):377-85. PubMed ID: 22146979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
    Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
    IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative functional variants of PI3K/AKT/mTOR pathway are associated with knee osteoarthritis susceptibility.
    Wang K; Chu M; Wang F; Zhao Y; Chen H; Dai X
    J Clin Lab Anal; 2020 Jun; 34(6):e23240. PubMed ID: 32052902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A GG allele of 3'-side AKT1 SNP is associated with decreased AKT1 activation and better prognosis of gastric cancer.
    Wang X; Lin Y; Lan F; Yu Y; Ouyang X; Wang X; Huang Q; Wang L; Tan J; Zheng F
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1399-411. PubMed ID: 24737346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in mTOR-pathway-related genes contribute to osteoarthritis susceptibility.
    Xu Z; Yang H; Zhou X; Li J; Jiang L; Li D; Wu L; Huang Y; Xu N
    Int Immunopharmacol; 2019 Dec; 77():105960. PubMed ID: 31704287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphisms rs701848 and rs2735343 in PTEN increases cancer risks in an Asian population.
    Song DD; Zhang Q; Li JH; Hao RM; Ma Y; Wang PY; Xie SY
    Oncotarget; 2017 Nov; 8(56):96290-96300. PubMed ID: 29221206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.